Хайлтын үр дүнгүүд - Rahul Aggarwal

Үр дүнг сайжруулах
  1. 1
    Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients

    Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients -н Rahul Aggarwal, Benjamin Petrie, Wasif Bala, Nicholas Chiu

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020

    Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020 -н Rahul Aggarwal, Robert W. Yeh, Karen E. Joynt Maddox, Rishi K. Wadhera

    Хэвлэсэн 2023
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Trends in Lipid Concentrations and Lipid Control Among US Adults, 2007-2018

    Trends in Lipid Concentrations and Lipid Control Among US Adults, 2007-2018 -н Rahul Aggarwal, Deepak L. Bhatt, Fátima Rodríguez, Robert W. Yeh, Rishi K. Wadhera

    Хэвлэсэн 2022
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    The MELD-Plus: A generalizable prediction risk score in cirrhosis

    The MELD-Plus: A generalizable prediction risk score in cirrhosis -н Uri Kartoun, Kathleen E. Corey, Tracey G. Simon, Hui Zheng, Rahul Aggarwal, Kenney Ng, Stanley Y. Shaw

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden

    Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden -н Victoria E. Wang, Anatoly Urisman, Lee A. Albacker, Siraj M. Ali, Vincent A. Miller, Rahul Aggarwal, David M. Jablons

    Хэвлэсэн 2017
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Racial/Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018

    Racial/Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018 -н Rahul Aggarwal, Nicholas Chiu, Rishi K. Wadhera, Andrew E. Moran, Inbar Raber, Changyu Shen, Robert W. Yeh, Dhruv S. Kazi

    Хэвлэсэн 2021
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Cardiovascular Health of Middle-Aged U.S. Adults by Income Level, 1999 to March 2020

    Cardiovascular Health of Middle-Aged U.S. Adults by Income Level, 1999 to March 2020 -н Michael Liu, Rahul Aggarwal, ZhaoNian Zheng, Robert W. Yeh, Dhruv S. Kazi, Karen E. Joynt Maddox, Rishi K. Wadhera

    Хэвлэсэн 2023
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis

    The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis -н Ronald Chow, James Im, Nicholas Chiu, Leonard Chiu, Rahul Aggarwal, Jihui Lee, Young‐Geun Choi, Elizabeth Horn Prsic, Hyun Joon Shin

    Хэвлэсэн 2021
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Pre- or post-chemotherapy: effect on PSMA uptake

    Pre- or post-chemotherapy: effect on PSMA uptake -н Surekha Yadav, Abuzar Moradi Tuchayi, Moein Moradpour, Fei Jiang, Roxanna Juarez, Ivan de Kouchkovsky, Robert R. Flavell, Rahul Aggarwal, Thomas A. Hope

    Хэвлэсэн 2025
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    Systemic nature of spinal muscular atrophy revealed by studying insurance claims

    Systemic nature of spinal muscular atrophy revealed by studying insurance claims -н Scott Lipnick, Denis Agniel, Rahul Aggarwal, Nina R. Makhortova, Samuel G. Finlayson, Alexandra Brocato, Nathan Palmer, Basil T. Darras, Isaac S. Kohane, Lee L. Rubin

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    <sup>68</sup>Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience

    <sup>68</sup>Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience -н Thomas A. Hope, Charles Truillet, Eric C. Ehman, Ali Afshar‐Oromieh, Rahul Aggarwal, Charles J. Ryan, Peter R. Carroll, Eric J. Small, Michael J. Evans

    Хэвлэсэн 2016
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms

    DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms -н James C. Yao, Emily K. Bergsland, Rahul Aggarwal, Ana M. Aparicio, Himisha Beltran, Judy S. Crabtree, Christine L. Hann, Toni Ibrahim, Lauren A. Byers, Hironobu Sasano, John Umejiego, Marianne Pavel

    Хэвлэсэн 2022
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Impact of <sup>68</sup>Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer

    Impact of <sup>68</sup>Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer -н Thomas A. Hope, Rahul Aggarwal, Bryant H. Chee, Dora Tao, Kirsten L. Greene, Matthew R. Cooperberg, Felix Feng, Albert J. Chang, Charles J. Ryan, Eric J. Small, Peter R. Carroll

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer

    Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer -н Emerson A. Lim, Michael T. Schweizer, Kim N., Rahul Aggarwal, Neeraj Agarwal, James L. Gulley, Edward F. Attiyeh, James Greger, Shujian Wu, Pharavee Jaiprasart, John T. Loffredo, Nibedita Bandyopadhyay, Hong Xie, Aaron R. Hansen

    Хэвлэсэн 2023
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    Initial Experience with<sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer

    Initial Experience with<sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer -н Vadim S. Koshkin, Vipul Kumar, Brad Kline, Domenique Escobar, Maya Aslam, Matthew R. Cooperberg, Rahul Aggarwal, Ivan de Kouchkovsky, Jonathan Chou, Maxwell V. Meng, Terence W. Friedlander, Sima P. Porten, Thomas A. Hope

    Хэвлэсэн 2024
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  16. 16
    Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies

    Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies -н Rahul Aggarwal, Scott Thomas, Nela Pawłowska, Imke H. Bartelink, Jennifer A. Grabowsky, Thierry Jahan, Amy Cripps, Armand Harb, Jim Leng, Anne Reinert, Ilaria Mastroserio, Thach-Giao Truong, Charles J. Ryan, Pamela N. Münster

    Хэвлэсэн 2017
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  17. 17
    Potential global impact of <scp>sodium–glucose</scp> cotransporter‐2 inhibitors in heart failure

    Potential global impact of <scp>sodium–glucose</scp> cotransporter‐2 inhibitors in heart failure -н Khawaja M. Talha, Javed Butler, Stephen J. Greene, Rahul Aggarwal, Stefan D. Anker, Brian Claggett, Kieran F. Docherty, Scott D. Solomon, John J.V. McMurray, James L. Januzzi, Muthiah Vaduganathan, Gregg C. Fonarow

    Хэвлэсэн 2023
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  18. 18
    Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants

    Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants -н Rahul Aggarwal, Christian T. Ruff, Saverio Virdone, Sylvie Perreault, Ajay K. Kakkar, Michael G. Palazzolo, Marc Dorais, Gloria Kayani, Daniel E. Singer, Eric A. Secemsky, Jonathan P. Piccini, Usman A. Tahir, Changyu Shen, Robert W. Yeh

    Хэвлэсэн 2023
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  19. 19
    Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low‐Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE‐IT Randomized Trial

    Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low‐Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE‐IT Randomized Trial -н Rahul Aggarwal, Deepak L. Bhatt, Philippe Gabríel Steg, Michael Miller, Eliot A. Brinton, Richard L. Dunbar, Steven B. Ketchum, Jean‐Claude Tardif, F M A C Martens, Christie M. Ballantyne, Michael Szarek, R. Preston Mason

    Хэвлэсэн 2025
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  20. 20
    Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer

    Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer -н Janice M. Mehnert, Andréa Varga, Marcia S. Brose, Rahul Aggarwal, Chia‐Chi Lin, Amy Prawira, Filippo de Braud, Kenji Tamura, Toshihiko Doi, Sarina A. Piha‐Paul, Jill Gilbert, Sanatan Saraf, Pradeep Thanigaimani, Jonathan D. Cheng, Bhumsuk Keam

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: